Michallet, A.-S.
89  Ergebnisse:
?
1

Centre characteristics and procedure-related factors have a..:

Schetelig, Johannes ; de Wreede, Liesbeth C ; Andersen, Niels S...
Schetelig , J , de Wreede , L C , Andersen , N S , Moreno , C , van Gelder , M , Vitek , A , Karas , M , Michallet , M , Machaczka , M , Gramatzki , M , Beelen , D , Finke , J , Delgado , J , Volin , L , Passweg , J , Dreger , P , Schaap , N , Wagner , E , Henseler , A , van Biezen , A , Bornhaeuser , M , Iacobelli , S , Putter , H , Schoenland , S O , Kroger , N , CLL Subcomm & Chronic Malignancies Working Party 2017 , ' Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL : a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT) ' , British Journal of Haematology , vol. 178 , no. 4 , pp. 521-533 . https://doi.org/10.1111/bjh.14791.  , 2017
 
?
3

P611: NEXT-CLL: A NEW NGS-BASED METHOD FOR RAPID ASSESSMENT..:

E. Bourbon ; K. Chabane ; A.-S. Michallet...
http://journals.lww.com/10.1097/01.HS9.0000845332.21493.41.  , 2022
 
?
4

P672: REAL-LIFE EFFICACY AND SAFETY OF VENETOCLAX MONOTHERA..:

L. Ysebaert ; X. Troussard ; V. Levy...
http://journals.lww.com/10.1097/01.HS9.0000845572.12203.da.  , 2022
 
?
5

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044.  , 2021
 
?
6

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844579/.  , 2021
 
?
7

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044.  , 2021
 
?
8

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044.  , 2021
 
?
9

Immune checkpoint inhibitor treatment of a first cancer is ..:

Heudel, P ; Chabaud, S ; Perol, D...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2020.100044.  , 2021
 
?
11

Occurrence of graft-versus-host disease increases mortality..:

Baron, F ; Ruggeri, A ; Beohou, E...
Baron , F , Ruggeri , A , Beohou , E , Labopin , M , Mohty , M , Sanz , J , Vigouroux , S , Furst , S , Bosi , A , Chevallier , P , Cornelissen , J , Michallet , M , Sierra , J , Karakasis , D , Savani , BN , Gluckman , E & Nagler , A 2018 , ' Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT ' , Journal of Internal Medicine , vol. 283 , no. 2 , pp. 178-189 . https://doi.org/10.1111/joim.12696.  , 2018
 
?
12

Risk factors for treatment failure after allogeneic transpl..:

Schetelig, J ; de Wreede, L. C ; van Gelder, M...
Schetelig , J , de Wreede , L C , van Gelder , M , Andersen , N S , Moreno , C , Vitek , A , Karas , M , Michallet , M , Machaczka , M , Gramatzki , M , Beelen , D , Finke , J , Delgado , J , Volin , L , Passweg , J , Dreger , P , Henseler , A , van Biezen , A , Bornhaeuser , M , Schoenland , S O , Kroeger , N , CLL Subcomm & Chronic Malignancies Working Party 2017 , ' Risk factors for treatment failure after allogeneic transplantation of patients with CLL : a report from the European Society for Blood and Marrow Transplantation ' , Bone Marrow Transplantation , vol. 52 , no. 4 , pp. 552-560 . https://doi.org/10.1038/bmt.2016.329.  , 2017
 
?
13

Long-term survival of patients with CLL after allogeneic tr..:

van Gelder, M ; de Wreede, L. C ; Bornhaeuser, M...
van Gelder , M , de Wreede , L C , Bornhaeuser , M , Niederwieser , D , Karas , M , Anderson , N S , Gramatzki , M , Dreger , P , Michallet , M , Petersen , E , Bunjes , D , Potter , M , Beelen , D , Cornelissen , J J , Yakoub-Agha , I , Russell , N H , Finke , J , Schoemans , H , Vitek , A , Urbano-Ispizua , A , Blaise , D , Volin , L , Chevallier , P , Caballero , D , Putter , H , van Biezen , A , Henseler , A , Schoenland , S , Kroeger , N , Schetelig , J & Chronic Malignancy Working Party 2017 , ' Long-term survival of patients with CLL after allogeneic transplantation : a report from the European Society for Blood and Marrow Transplantation ' , Bone Marrow Transplantation , vol. 52 , no. 3 , pp. 372-380 . https://doi.org/10.1038/bmt.2016.282.  , 2017
 
?
 
?
15

Synergistic activity of vorinostat combined with gefitinib ..:

Jeannot V ; Busser B ; Vanwonterghem L...
https://www.dovepress.com/synergistic-activity-of-vorinostat-combined-with-gefitinib-but-not-wit-peer-reviewed-article-OTT.  , 2016
 
1-15